Daniel Stauder
Stock Analyst at JMP Securities
(3.12)
# 1,132
Out of 4,873 analysts
17
Total ratings
50%
Success rate
2.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Reiterates: Market Outperform | $33 | $30.85 | +6.97% | 4 | May 6, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $31.90 | +88.09% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $3.43 | +104.08% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $83.38 | +31.93% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $783.24 | -7.44% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $12.11 | - | 1 | May 7, 2024 |
Artivion
May 6, 2025
Reiterates: Market Outperform
Price Target: $33
Current: $30.85
Upside: +6.97%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $31.90
Upside: +88.09%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $3.43
Upside: +104.08%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $83.38
Upside: +31.93%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $783.24
Upside: -7.44%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.11
Upside: -